ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,040.53
      -0.50%
      US Tech 100
      20,778.00
      -0.69%
      Dow Jones
      44,544.66
      -0.75%
      Brent Oil
      76.385
      0.00%
      Bitcoin
      100,635.04
      -1.74%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Brazil
      5. BOV

      6. Abbott Laboratories (ABTT34) Quote

      Abbott Laboratories

      Abbott Laboratories (ABTT34)

      BOV
      62.46
      -0.66
      (-1.05%)
      Closed February 01 3:55PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      62.46
      Bid
      59.98
      Ask
      64.00
      Volume
      11
      62.41 Day's Range 63.14
      43.47 52 Week Range 63.82
      Market Cap
      108.434B
      Previous Close
      63.12
      Open
      63.14
      Last Trade
      5
      @
      62.46
      Last Trade Time
      Financial Volume
      R$ 687
      VWAP
      62.499
      Average Volume (3m)
      673
      Shares Outstanding
      1,736,059,000
      Dividend Yield
      1.33%
      PE Ratio
      38.81
      Earnings Per Share (EPS)
      3.3
      Revenue
      40.11B
      Net Profit
      5.72B

      About Abbott Laboratories

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.abbott.com
      Headquarters
      Chicago, Illinois, USA
      Founded
      -
      Abbott Laboratories is listed in the Pharmaceutical Preparations sector of the Brazil Bovespa Exchange with ticker ABTT34. The last closing price for Abbott Laboratories was R$63.12. Over the last year, Abbott Laboratories shares have traded in a share price range of R$ 43.47 to R$ 63.82.

      Abbott Laboratories currently has 1,736,059,000 shares outstanding. The market capitalization of Abbott Laboratories is R$109.58 billion. Abbott Laboratories has a price to earnings ratio (PE ratio) of 38.81.

      Ask ADVFN Intelligence (AI)

      ABTT34 Latest News

      More News
      No news to show yet.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      11.462.393442622956163.826120961.89558429DR
      44.78.1371191135757.7663.8253.5838457.94607096DR
      127.4113.460490463255.0563.8253.5867357.94069899DR
      2612.7125.547738693549.7563.8249.242656.54478994DR
      5217.4538.769162408445.0163.8243.4738752.65685358DR
      1566.9122267212.443751228655.5477732863.8237.5167346.50935848DR
      26031.52571129101.91186739630.9342887167.4063615528.75849266111348.35893224DR

      ABTT34 - Frequently Asked Questions (FAQ)

      What is the current Abbott Laboratories share price?
      The current share price of Abbott Laboratories is R$ 62.46
      How many Abbott Laboratories shares are in issue?
      Abbott Laboratories has 1,736,059,000 shares in issue
      What is the market cap of Abbott Laboratories?
      The market capitalisation of Abbott Laboratories is BRL 109.58B
      What is the 1 year trading range for Abbott Laboratories share price?
      Abbott Laboratories has traded in the range of R$ 43.47 to R$ 63.82 during the past year
      What is the PE ratio of Abbott Laboratories?
      The price to earnings ratio of Abbott Laboratories is 38.81
      What is the cash to sales ratio of Abbott Laboratories?
      The cash to sales ratio of Abbott Laboratories is 5.54
      What is the reporting currency for Abbott Laboratories?
      Abbott Laboratories reports financial results in USD
      What is the latest annual turnover for Abbott Laboratories?
      The latest annual turnover of Abbott Laboratories is USD 40.11B
      What is the latest annual profit for Abbott Laboratories?
      The latest annual profit of Abbott Laboratories is USD 5.72B
      What is the registered address of Abbott Laboratories?
      The registered address for Abbott Laboratories is 208 SO LASALLE ST, SUITE 814, CHICAGO, ILLINOIS, 60604-1101
      What is the Abbott Laboratories website address?
      The website address for Abbott Laboratories is www.abbott.com
      Which industry sector does Abbott Laboratories operate in?
      Abbott Laboratories operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      PGMN11Empreendimentos Pague Menos S.A.
      R$ 0.49
      (40.00%)
      		2.7k
      CTKA3Karsten Sa ex Cia Textil Karsten
      R$ 24.50
      (14.22%)
      		300
      AZEV4Azevedo Travassos Sa
      R$ 1.30
      (12.07%)
      		10.66M
      TELB3Telec Brasileiras-Telebras
      R$ 13.20
      (10.46%)
      		1.1k
      PEAB4Cia Participacoes Alianca Bahia
      R$ 51.98
      (9.43%)
      		1,000
      IFCM3Infracommerce Caxaas S.A.
      R$ 0.07
      (-12.50%)
      		4.69M
      NGRD3Neogrid Participacoes SA
      R$ 20.33
      (-6.66%)
      		52.7k
      LPSB3Lps Brasil Consultoria Imoveis Sa
      R$ 1.30
      (-5.80%)
      		199.8k
      ZAMP3Zamp S.A.
      R$ 2.91
      (-5.21%)
      		450.2k
      VBBR3Vibra Energia S.A.
      R$ 16.86
      (-5.07%)
      		22.37M
      AMOB3Automob Participacoes Sa
      R$ 0.31
      (0.00%)
      		55.98M
      HAPV3Hapvida Participacoes Investimento SA
      R$ 2.42
      (-1.22%)
      		55.62M
      COGN3CognaEducacao SA
      R$ 1.41
      (1.44%)
      		39.92M
      BBDC4Bco Bradesco Sa
      R$ 12.09
      (-0.411862%)
      		37.53M
      PETR4Petroleo Brasileiro S.A. Petrobras
      R$ 37.69
      (0.802354%)
      		37.04M

      Discussion

      View Full Feed
      improving improving 4 minutes ago
      Ridiculous comment, of course punitive damages remain on the table.
      Tell your law school you want your money back. Bash on brother.
      NWBO
      Controlledoilandgas Controlledoilandgas 4 minutes ago
      Not sure we agree with calling Button Energy a hope and dream... Cohen already bought 25% of the company on a private basis last July... you can also see that listed on his LinkedIn.

      Did you read that LOI that they executed? We  included the filing to it below.

      AZRH
      carvajal carvajal 5 minutes ago

      " style="font-size: 1em"Inform the criterion for calculating the emission price and justify, in detail, the economic aspects that determined its choice, in accordance with Article
      HMBL
      skitahoe skitahoe 5 minutes ago
      Of course I should have added that no one really knows what a jury will award in punitive damages. A jury can never really be certain of how much is paid as after all the dust settles the actual payment could be substantially more, or less than what the jury said it should be. I don't know if that
      NWBO
      snupoled snupoled 5 minutes ago
      Do we still do guesses? 19,100,000 revs
      Looking forward to near term Percocet and methadone launches
      Some coloring in on all things Vyvanse
      When is investors relations going to aggressive,
      Lots to talk about.
      Snup
      ELTP
      StayHumble StayHumble 5 minutes ago
      wow💹16 BILLION+Historic BUYS✅Lots of Xperts Here💹 https://ih.advfn.com/stock-market/USOTC/humbl-pk-HMBL/historical
      https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif
      HMBL
      tm3141 tm3141 7 minutes ago
      saw the posts on x about it, will be interesting to know how relevant it is to fnf now and future, besides the unnecessary regulations 
      FNMA
      DP1011 DP1011 8 minutes ago
      100% entertainment value. 😂🤣
      PHIL
      Lime Time Lime Time 9 minutes ago
      They still keeping it current. It goes from 70m bid to zero bid some days. Very strange. I think a pump group will target this some time this year, or else reverse merger candidate. Let's see the pump 8k again 🚀
      ATYG
      MasterBlastr MasterBlastr 9 minutes ago
      Crowded at the top - anybody's game. Calmer winds earlier could let someone else from below contend.
      Stevenvegas Stevenvegas 11 minutes ago
      I flipped out AH. traded funky and PR is ummmm suspect lol But maybe she gaps on Monday
      jimr1717 jimr1717 11 minutes ago
      The more Sold IFUS gets the lower the price. Hence the.14 to .02.
      IFUS
      skitahoe skitahoe 14 minutes ago
      I'm no expert, but I suspect that if a settlement is agreed to prior to discovery, it might be for more than what might be awarded by a jury, even with penalties included. Why? Because the 7 MM's would have not revealed anything to anyone. The question is, how much is it worth to them not to open
      NWBO
      Genz2 Genz2 14 minutes ago
      https://www.teslarati.com/tesla-underrated-benefit-fsd-supervised/amp/

      And just think if you take a trip for wine tasting in Napa Valley, you have a glass of wine, and could get busted for DUI!! I don’t drink, but for those that do, Tesla and FSD could boost business in Napa Valley,
      TSLA
      CrapIsCrap CrapIsCrap 14 minutes ago
      Entertainment value
      PHIL
      Jetmek_03052 Jetmek_03052 14 minutes ago
      I think your concern is unwarranted.

      There’s plenty of leadership and the AI picture hasn’t completely changed just because one Chinese company has made claims that (at this point) are not entirely proven.

      AI future is still bright.
      NVDA
      delerious1 delerious1 15 minutes ago
      Should be an interesting week
      Nobody Being Reasonably Intelligent (N.B.R.I.) would question what amazing progress that our team led by jared Lazerson, has acheived so far ...it's Nice Being Really Invested (N.B.R.I.) in what has been going on these last 4 or more months with so many New Begin
      NBRI
      XMaster2023 XMaster2023 15 minutes ago
      To the contrary, on Monday you will see an abnormal volume of trading will take place. Your bosses will be disappointed.
      Approval is near.
      NWBO
      NeutrinoKid NeutrinoKid 16 minutes ago
      And this. This is smashing. Results of human trial of Ampakine CX717.

      Daniel P. Radin, Rok Cerne, Jodi L. Smith, Jeffrey M. Witkin, Arnold Lippa,
      Safety, Tolerability and Pharmacokinetic Profile of the Low-Impact Ampakine CX717 in Young Healthy Male Subjects and Elderly Healthy
      RSPI
      canthelpit canthelpit 18 minutes ago
      GTCH PORCH GTCH post #22933 12/19/24 nailed it !! I am not always wrong ,, I get one in once in awhile. GLTA
      GTCH
      huang guo qing huang guo qing 19 minutes ago
      the presidend signedan executive order last night fire the CFPB you all don't know
      FNMA
      NeutrinoKid NeutrinoKid 21 minutes ago
      Okay, don’t get too excited. This just came up.

      Daniel P. Radin, Arnold Lippa, Sabhya Rana, David D. Fuller, Jodi L. Smith, Rok Cerne, Jeffrey M. Witkin,
      Amplification of the therapeutic potential of AMPA receptor potentiators from the nootropic era to today,
      Pharmacolog
      RSPI
      michael702/ michael702/ 23 minutes ago
      Gave other company 6 years and give this company 6 months, nice of you!
      BLLB
      nowwhat2 nowwhat2 24 minutes ago
      https://investorshub.advfn.com/uimage/uploads/2025/2/1/dttcaxrp_@_1_CAPT_333pm_ROCKER_horiz_diag_narrate_lesson.jpg





      I'm here to collaborate with those who are (ideally), accustomed to working with them.



      .

      XRPUSD
      luckydude777 luckydude777 25 minutes ago
      I've started a new YouTube channel for beginning stock market investors, logging my buys and sells, for those interested: https://www.youtube.com/@NormRasmussen-w2x
      SQQQ

      Your Recent History

      BOV
      ABTT34
      Abbott Laboratories
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads